Keyphrases
Vascular Graft
100%
Controlled Release
100%
1,8-octanediol
100%
Polytetrafluoroethylene Graft
85%
Citrate
85%
Peripheral Arterial Disease
71%
All-trans Retinoic Acid
71%
Intimal Hyperplasia
71%
Thrombosis
57%
Expanded Polytetrafluoroethylene (ePTFE)
57%
Patency Rate
42%
Biocompatibility
28%
Bypass Model
28%
Bypass Grafting
28%
Non-thrombogenic
28%
Overgrowth
28%
Controlled Drug Release
28%
Successful Completion
14%
Smooth muscle Cell Proliferation
14%
Polymer-coated
14%
Clot
14%
Drug Candidates
14%
Carotid Artery Bypass
14%
Degradation Degree
14%
Smooth muscle Cells
14%
Lower Extremity
14%
Venous Disease
14%
Polymerization Conditions
14%
Porcine
14%
Potential Alternatives
14%
Carotid Artery
14%
Vascular Endothelial Cells
14%
Blood Flow
14%
Limb Amputation
14%
Lower Extremity Bypass
14%
Bypass Graft
14%
Muscular Artery
14%
Endothelial Cells
14%
Potential Drugs
14%
Anti-thrombogenic Property
14%
Releasing Drug
14%
Porcine Carotid Artery
14%
Innovative Products
14%
Vein Harvesting
14%
Patency
14%
Porcine Model
14%
Surface Modification
14%
Gradual Reduction
14%
Limb Salvage
14%
Swelling Degree
14%
Vascular Disease
14%
Citrate Polymers
14%
Occlusion
14%
Release Rate
14%
Blood Clot
14%
Graft Failure
14%
Grafting from
14%
Nitric Oxide
14%
Swelling Rate
14%
Degradation Rate
14%
Inflammation
14%
Small Molecules
14%
Lumen
14%
Specific Intent
14%
Public Health
14%
Patient Care
14%
United States
14%
Medicine and Dentistry
Politef
100%
Blood Vessel Graft
100%
Controlled Release
100%
Neointimal Hyperplasia
50%
Arteriosclerosis Obliterans
50%
Tretinoin
50%
Thrombosis
40%
In Vitro
20%
Smooth Muscle Cell
20%
Carotid Artery
20%
Cell Proliferation
10%
Blood Clotting
10%
Artery Bypass
10%
Vein Disease
10%
Limb Salvage
10%
Blood Flow
10%
Bypass Surgery
10%
Graft Failure
10%
Limb Amputation
10%
Nitric Oxide
10%
Antithrombotic
10%
Endothelial Cell
10%
Vascular Endothelial Cell
10%
Controlled Drug Release
10%
Atherosclerosis
10%
Artery
10%
Vascular Disease
10%
Pharmacology, Toxicology and Pharmaceutical Science
Controlled Release
100%
Politef
100%
Retinoic Acid
50%
Peripheral Occlusive Artery Disease
50%
Hyperplasia
50%
Thrombosis
40%
Pig
30%
Drug Release
10%
Graft Failure
10%
Vein Disease
10%
Anticoagulant Agent
10%
Controlled Drug Release
10%
Atherosclerosis
10%
Nitric Oxide
10%
Inflammation
10%
Vascular Disease
10%